Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-669899f699-ggqkh Total loading time: 0 Render date: 2025-05-05T06:45:01.887Z Has data issue: false hasContentIssue false

27 - Primary Brain Tumors and Cerebral Metastases

from PART II - CLINICAL RESEARCH

Published online by Cambridge University Press:  05 June 2012

By
Matthew C. Tate  and
Mitchel S. Berger
Edited by
David Lyden ,
Danny R. Welch  and
Bethan Psaila
Matthew C. Tate
Affiliation:
University of California, San Francisco, United States
Mitchel S. Berger
Affiliation:
University of California, San Francisco, United States
David Lyden
Affiliation:
Weill Cornell Medical College, New York
Danny R. Welch
Affiliation:
Weill Cornell Medical College, New York
Bethan Psaila
Affiliation:
Imperial College of Medicine, London
Get access

Summary

Metastatic brain tumors (MBT) are the most common tumor type encountered in the brain. As survival of patients with primary tumors has improved over time, the incidence of MBT has increased. In this chapter, the basic biological and clinical aspects of metastatic spread to the brain are presented, including an overview of the epidemiology of MBT and recent advances in tumor biology particularly relevant to brain metastasis. Therapeutic strategies for MBT, including surgery, radiation, and chemotherapy, are reviewed, with an emphasis on application of randomized clinical trial data to practice guidelines. Finally, systemic metastases of primary brain tumors are discussed. Although relatively rare in comparison to metastases of systemic cancers to the brain, the frequency of extraneural metastases is increasing as therapy for primary brain tumors improves, thus warranting consideration.

INTRACRANIAL METASTASES

Epidemiology

Brain metastases are the most common intracranial tumor seen in adults, with approximately 10 percent of adults with cancer developing symptomatic brain metastases [1]. In the United States, the estimated prevalence of brain metastases is 200,000 cases per year [2], with an incidence of 8.2 per 100,000 persons [3]. The three most common primary cancers that metastasize to the brain are lung (38%), breast (19%), and melanoma (13%). Among these, melanoma demonstrates the highest likelihood of metastasis, with a rate approaching 50 percent in patients diagnosed with the disease.

Type
Chapter
Information
Cancer Metastasis
Biologic Basis and Therapeutics
 , pp. 282 - 293
Publisher: Cambridge University Press
Print publication year: 2011

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Book purchase

Temporarily unavailable

References

Barnholtz-Sloan, JS et al. (2004) Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncol. 22(14): 2865–72.CrossRefGoogle ScholarPubMed
Eichler, AF, Loeffler, JS (2007) Multidisciplinary management of brain metastases. Oncologist. 12(7): 884–98.CrossRefGoogle ScholarPubMed
Walker, AE, Robins, M, Weinfeld, FD (1985) Epidemiology of brain tumors: the national survey of intracranial neoplasms. Neurology. 35(2): 219–26.CrossRefGoogle ScholarPubMed
Delattre, JY et al. (1988) Distribution of brain metastases. Arch Neurol. 45(7): 741–4.CrossRefGoogle ScholarPubMed
Nussbaum, ES et al. (1996) Brain metastases. Histology, multiplicity, surgery, and survival. Cancer. 78(8): 1781–8.3.0.CO;2-U>CrossRefGoogle Scholar
Santarelli, JG et al. (2007) Molecular events of brain metastasis. Neurosurg Focus. 22(3): E1.CrossRefGoogle ScholarPubMed
Marchetti, D, Li, J, Shen, R (2000) Astrocytes contribute to the brain-metastatic specificity of melanoma cells by producing heparinase. Cancer Res. 60(17): 4767–70.Google Scholar
DeAngelis, LM (2002) Intracranial Tumors: Diagnosis and Treatment. London, Florence, KY: Martin Dunitz, p. viii.Google Scholar
Patchell, RA et al. (1990) A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med. 322(8): 494–500.CrossRefGoogle Scholar
Mukwaya, G (1988) Immunosuppressive effects and infections associated with corticosteroid therapy. Pediatr Infect Dis J. 7(7): 499–504.CrossRefGoogle ScholarPubMed
Raizer, JJ, Abrey, (2007) Brain Metastases. Cancer Treatment and Research. New York: Springer.Google Scholar
Newton, HB et al. (1999) Clinical presentation, diagnosis, and pharmacotherapy of patients with primary brain tumors. Ann Pharmacother. 33(7–8): 816–32.CrossRefGoogle ScholarPubMed
Bateman, et al. (1988) Amino acid neurotransmitter levels in gliomas and their relationship to the incidence of epilepsy. Neurol Res. 10(2): 112–4.CrossRefGoogle ScholarPubMed
Haglund, MM et al. (1992) Changes in gamma-aminobutyric acid and somatostatin in epileptic cortex associated with low-grade gliomas. J Neurosurg. 77(2): 209–16.CrossRefGoogle ScholarPubMed
Schaller, B, Ruegg, SJ (2003) Brain tumor and seizures: pathophysiology and its implications for treatment revisited. Epilepsia. 44(9): 1223–32.CrossRefGoogle ScholarPubMed
Glantz, MJ et al. (1996) A randomized, blinded, placebo-controlled trial of divalproex sodium prophylaxis in adults with newly diagnosed brain tumors. Neurology. 46(4): 985–91.CrossRefGoogle ScholarPubMed
Sawaya, R, Glas-Greenwalt, P (1992) Postoperative venous thromboembolism and brain tumors: Part II. Hemostatic profile. J Neurooncol. 14(2): 127–34.Google ScholarPubMed
Danish, SF et al. (2005) Prophylaxis for deep venous thrombosis in craniotomy patients: a decision analysis. Neurosurgery. 56(6): 1286–92; discussion 1292–4.CrossRefGoogle ScholarPubMed
Weitz, JI (1997) Low-molecular-weight heparins. N Engl J Med. 337(10): 688–98.CrossRefGoogle ScholarPubMed
Fife, KM et al. (2004) Determinants of outcome in melanoma patients with cerebral metastases. J Clin Oncol. 22(7): 1293–300.CrossRefGoogle ScholarPubMed
Lagerwaard, FJ et al. (1999) Identification of prognostic factors in patients with brain metastases: a review of 1292 patients. Int J Radiat Oncol Biol Phys. 43(4): 795–803.CrossRefGoogle ScholarPubMed
Gaspar, et al. (2000) Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. Int J Radiat Oncol Biol Phys. 47(4): 1001–6.CrossRefGoogle ScholarPubMed
Weltman, E et al. (2000) Radiosurgery for brain metastases: a score index for predicting prognosis. Int J Radiat Oncol Biol Phys. 46(5): 1155–61.CrossRefGoogle ScholarPubMed
Lorenzoni, J et al. (2004) Radiosurgery for treatment of brain metastases: estimation of patient eligibility using three stratification systems. Int J Radiat Oncol Biol Phys. 60(1): 218–24.CrossRefGoogle ScholarPubMed
Sperduto, PW et al. (2008) A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1960 patients in the RTOG database. Int J Radiat Oncol Biol Phys. 70(2): 510–4.CrossRefGoogle ScholarPubMed
Khuntia, D et al. (2006) Whole-brain radiotherapy in the management of brain metastasis. J Clin Oncol. 24(8): 1295–304.CrossRefGoogle ScholarPubMed
Tsao, MN et al. (2006) Whole brain radiotherapy for the treatment of multiple brain metastases. Cochrane Database Syst Rev. 3: CD003869.Google Scholar
Mehta, MP et al. (2003) Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases. J Clin Oncol. 21(13): 2529–36.CrossRefGoogle Scholar
Suh, JH et al. (2006) Phase III study of efaproxiral as an adjunct to whole-brain radiation therapy for brain metastases. J Clin Oncol. 24(1): 106–14.CrossRefGoogle ScholarPubMed
, Shaw E et al. (2000) Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90–05. Int J Radiat Oncol Biol Phys. 47(2): 291–8.CrossRefGoogle Scholar
Shehata, MK et al. (2004) Stereotactic radiosurgery of 468 brain metastases < or = 2 cm: implications for SRS dose and whole brain radiation therapy. Int J Radiat Oncol Biol Phys. 59(1): 87–93.CrossRefGoogle ScholarPubMed
Kondziolka, D et al. (1999) Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys. 45(2): 427–34.CrossRefGoogle ScholarPubMed
Andrews, DW et al. (2004) Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: Phase III results of the RTOG 9508 randomized trial. Lancet. 363(9422): 1665–72.CrossRefGoogle ScholarPubMed
Aoyama, H et al. (2006) Stereotactic radiosurgery plus whole-brain radiation therapy vs. stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA. 295(21): 2483–91.CrossRefGoogle ScholarPubMed
Meert, AP et al. (2001) Prophylactic cranial irradiation in small cell lung cancer: a systematic review of the literature with meta-analysis. BMC Cancer. 1: 5.CrossRefGoogle ScholarPubMed
Arriagada, R et al. (1995) Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. J Natl Cancer Inst. 87(3): 183–90.CrossRefGoogle ScholarPubMed
Gregor, A et al. (1997) Prophylactic cranial irradiation is indicated following complete response to induction therapy in small cell lung cancer: results of a multicentre randomized trial. United Kingdom Coordinating Committee for Cancer Research (UKCCCR) and the European Organization for Research and Treatment of Cancer (EORTC). Eur J Cancer. 33(11): 1752–8.CrossRefGoogle ScholarPubMed
Gore, E (2005) RTOG 0214: a Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small cell lung cancer. Clin Adv Hematol Oncol. 3(8): 625–6.Google ScholarPubMed
Barker, FG 2nd (2004) Craniotomy for the resection of metastatic brain tumors in the U.S., 1988–2000: decreasing mortality and the effect of provider caseload. Cancer. 100(5): 999–1007.CrossRefGoogle ScholarPubMed
Katz, HR (1981) The relative effectiveness of radiation therapy, corticosteroids, and surgery in the management of melanoma metastatic to the central nervous system. Int J Radiat Oncol Biol Phys. 7(7): 897–906.CrossRefGoogle ScholarPubMed
Zimm, S et al. (1981) Intracerebral metastases in solid-tumor patients: natural history and results of treatment. Cancer. 48(2): 384–94.3.0.CO;2-8>CrossRefGoogle ScholarPubMed
Vecht, CJ et al. (1993) Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery?Ann Neurol. 33(6): 583–90.CrossRefGoogle ScholarPubMed
Mintz, AH et al. A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis. Cancer. (1996) 78(7): 1470–6.3.0.CO;2-X>CrossRefGoogle ScholarPubMed
Stark, AM et al. (2005) Surgical treatment for brain metastases: prognostic factors and survival in 177 patients. Neurosurg Rev. 28(2): 115–9.CrossRefGoogle ScholarPubMed
Bindal, AK et al. (1996) Surgery versus radiosurgery in the treatment of brain metastasis. J Neurosurg. 84(5): 748–54.CrossRefGoogle ScholarPubMed
Bernardo, G et al. (2002) First-line chemotherapy with vinorelbine, gemcitabine, and carboplatin in the treatment of brain metastases from non-small-cell lung cancer: a Phase II study. Cancer Invest. 20(3): 293–302.CrossRefGoogle ScholarPubMed
Kleisbauer, JP et al. (1990) Chemotherapy with high-dose cisplatin in brain metastasis of lung cancers. Bull Cancer. 77(7): 661–5.Google ScholarPubMed
Giorgio, CG et al. (2005) Oral temozolomide in heavily pre-treated brain metastases from non-small cell lung cancer: Phase II study. Lung Cancer. 50(2): 247–54.CrossRefGoogle ScholarPubMed
Omuro, AM et al. (2006) Vinorelbine combined with a protracted course of temozolomide for recurrent brain metastases: a Phase I trial. J Neurooncol. 78(3): 277–80.CrossRefGoogle ScholarPubMed
Ceresoli, GL et al. (2004) Gefitinib in patients with brain metastases from non-small-cell lung cancer: a prospective trial. Ann Oncol. 15(7): 1042–7.CrossRefGoogle ScholarPubMed
Shimato, S et al. (2006) EGFR mutations in patients with brain metastases from lung cancer: association with the efficacy of gefitinib. Neuro Oncol. 8(2): 137–44.CrossRefGoogle ScholarPubMed
Boogerd, W et al. (1992) Response of brain metastases from breast cancer to systemic chemotherapy. Cancer. 69(4): p. 972–80.3.0.CO;2-P>CrossRefGoogle ScholarPubMed
Cocconi, G et al. (1991) Cisplatin and etoposide as first-line chemotherapy for metastatic breast carcinoma: a prospective randomized trial of the Italian Oncology Group for Clinical Research. J Clin Oncol. 9(4): 664–9.CrossRefGoogle Scholar
Christodoulou, C et al. (2005) Temozolomide (TMZ) combined with cisplatin (CDDP) in patients with brain metastases from solid tumors: a Hellenic Cooperative Oncology Group (HeCOG) Phase II study. J Neurooncol. 71(1): 61–5.CrossRefGoogle ScholarPubMed
Rivera, E et al. (2006) Phase I study of capecitabine in combination with temozolomide in the treatment of patients with brain metastases from breast carcinoma. Cancer. 107(6): 1348–54.CrossRefGoogle ScholarPubMed
Lassman, AB et al. (2006) Systemic high-dose intravenous methotrexate for central nervous system metastases. J Neurooncol. 78(3): 255–60.CrossRefGoogle ScholarPubMed
Lin, NU et al. (2008) Phase II trial of lapatinib for brain metastases in patients with human epidermal growth factor receptor 2-positive breast cancer. J Clin Oncol. 26(12): 1993–9.CrossRefGoogle ScholarPubMed
Cavaliere, R, Schiff, D (2007) Chemotherapy and cerebral metastases: misperception or reality?Neurosurg Focus. 22(3): E6.CrossRefGoogle ScholarPubMed
Agarwala, SS et al. (2004) Temozolomide for the treatment of brain metastases associated with metastatic melanoma: a Phase II study. J Clin Oncol. 22(11): 2101–7.CrossRefGoogle ScholarPubMed
Danson, S et al. (2003) Randomized Phase II study of temozolomide given every 8 hours or daily with either interferon alfa-2b or thalidomide in metastatic malignant melanoma. J Clin Oncol. 21(13): 2551–7.CrossRefGoogle ScholarPubMed
Margolin, K et al. (2002) Temozolomide and whole brain irradiation in melanoma metastatic to the brain: a phase II trial of the Cytokine Working Group. J Cancer Res Clin Oncol. 128(4): 214–8.CrossRefGoogle ScholarPubMed
Weber, RW et al. (2005) Low-dose outpatient chemobiotherapy with temozolomide, granulocyte-macrophage colony stimulating factor, interferon-alpha2b, and recombinant interleukin-2 for the treatment of metastatic melanoma. J Clin Oncol. 23(35): 8992–9000.CrossRefGoogle ScholarPubMed
Chamberlain, MC, Nolan, C, Abrey, (2005) Leukemic and lymphomatous meningitis: incidence, prognosis and treatment. J Neurooncol. 75(1): 71–83.CrossRefGoogle ScholarPubMed
Platini, C, Long, J, Walter, S (2006) Meningeal carcinomatosis from breast cancer treated with intrathecal trastuzumab. Lancet Oncol. 7(9): 778–80.CrossRefGoogle ScholarPubMed
Rubenstein, JL et al. (2003) Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartment. Blood. 101(2): 466–8.CrossRefGoogle ScholarPubMed
Hoffman, HJ, Duffner, PK (1985) Extraneural metastases of central nervous system tumors. Cancer. 56(7Suppl): 1778–82.3.0.CO;2-I>CrossRefGoogle ScholarPubMed
Willis, RA (1952) The Spread of Tumors in the Human Body, 2nd ed. London: Butterworths Medical Publications, 321–404.Google Scholar
Pansera, F, Pansera, E (1992) An explanation for the rarity of extraaxial metastases in brain tumors. Med Hypotheses. 39(1): 88–9.CrossRefGoogle ScholarPubMed
McComb, JG (1983) Recent research into the nature of cerebrospinal fluid formation and absorption. J Neurosurg. 59(3): 369–83.CrossRefGoogle ScholarPubMed
Morley, TP (1959) The recovery of tumour cells from venous blood draining cerebral gliomas; a preliminary report. Can J Surg. 2(4): 363–5.Google ScholarPubMed
Battista, AF et al. (1961) Autotransplantation of anaplastic astrocytoma into the subcutaneous tissue of man. Neurology. 11: 977–81.CrossRefGoogle Scholar
Kleinman, GM, Hochberg, FH, Richardson, EP. (1981) Systemic metastases from medulloblastoma: report of two cases and review of the literature. Cancer. 48(10): 2296–309.3.0.CO;2-C>CrossRefGoogle ScholarPubMed
Park, TS et al. (1983) Medulloblastoma: clinical presentation and management. Experience at the Hospital for Sick Children, Toronto, 1950–1980. J Neurosurg. 58(4): 543–52.CrossRefGoogle Scholar
el-Gindi, S et al. (1973) Metastases of glioblastoma multiforme to cervical lymph nodes. Report of two cases. J Neurosurg. 38(5): 631–4.CrossRefGoogle ScholarPubMed
Nager, GT (1967) Gliomas involving the temporal bone clinical and pathological aspects. Laryngoscope. 77(4): 454–88.Google ScholarPubMed
Kaal, EC et al. (2005) Therapeutic management of metastasis. Lancet Neurology. 4(5): 289–98.CrossRefGoogle Scholar

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×